Dr. Procailo received her undergraduate degree in Biomedical Sciences from Western Michigan University and then went on to receive her PharmD from the University of Michigan in 2009. Dr. Procailo began her career as an Infusion Pharmacist at the Michigan Medicine Rogel Cancer Center. During her years at Michigan Medicine, she served and led in a variety of areas, including the Anemia Management Program, Oral Oncolytics Program, Cancer Center Orders team and finally as the Lead Infusion Pharmacist within Michigan Medicine’s cancer center, overseeing operations. Prior to joining MOQC in October 2018, she worked at Diplomat Specialty Pharmacy supervising oncology clinical programs and operations. She then transitioned to a Senior Consultant position at a large academic NCI-NCCN cancer institution, facilitating the roll-out of a new electronic medical record (EMR) system. Dr. Procailo currently serves on the University of Michigan College of Pharmacy Board of Governors, is a planning committee member of the Michigan Society of Hematology and Oncology (MSHO) Pharmacist Forum, and is a member of the Hematology and Oncology Pharmacists Association (HOPA) and American Society of Clinical Oncology (ASCO).
Dr. Procailo’s practice interests include oncology quality of care, chemotherapy safety, and patient access to oncology care. She also enjoys mentoring students, residents and interns as an Adjunct Clinical Instructor through the University of Michigan College of Pharmacy.